UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

2.420 An improved model of L-DOPA-induced dyskinesia in 6-OHDA lesioned rats

Parkinsonism & related disorders, 2007, Vol.13, p.S132-S133

2007

Volltextzugriff (PDF)

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

Proceedings of the National Academy of Sciences - PNAS, 1999-09, Vol.96 (19), p.10824-10829

1999

Volltextzugriff (PDF)

Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure

Molecular pharmacology, 1994-02, Vol.45 (2), p.182-188

1994

Volltextzugriff (PDF)

In Vitro Antioxidant Neuroprotective Activity of BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2079-2086

2000

Volltextzugriff (PDF)

Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors

Neuroendocrinology, 1996-02, Vol.63 (2), p.188

1996

Volltextzugriff (PDF)

Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon

Journal of vascular research, 1993-05, Vol.30 (3), p.139

1993

Volltextzugriff (PDF)

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Volltextzugriff (PDF)

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Blood, 2010-10, Vol.116 (14), p.2448-2454

2010

Volltextzugriff (PDF)

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6C high Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70-A71

2013

Volltextzugriff (PDF)

A9.17Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70-A71

2013

Volltextzugriff (PDF)

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A70

2013

Volltextzugriff (PDF)

A4.4MIR-146A deficiency in LY6Chigh monocytes contributes to pathogenic bone loss during inflammatory arthritis

Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A37-A38

2015

Volltextzugriff (PDF)

A4.4 MIR-146A deficiency in LY6C high monocytes contributes to pathogenic bone loss during inflammatory arthritis

Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A37-A38

2015

Volltextzugriff (PDF)

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

European journal of haematology, 2011-10, Vol.87 (4), p.338-348

2011

Volltextzugriff (PDF)

Increased rewarding properties of morphine in dopamine-transporter knockout mice

The European journal of neuroscience, 2000-05, Vol.12 (5), p.1827-1837

2000

Volltextzugriff (PDF)

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with -thalassemia major

Haematologica (Roma), 2012-06, Vol.97 (6), p.842-848

2012

Volltextzugriff (PDF)

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

Haematologica (Roma), 2011-01, Vol.96 (1), p.48-54

2011

Volltextzugriff (PDF)

410 Antitumoral activity of tasquinimod is mediated through tumour immunomodulatory and antiangiogenic properties in bladder cancer

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e410-e410

2014

Volltextzugriff (PDF)

Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells

Biochemical and biophysical research communications, 1989-10, Vol.164 (2), p.809-815

1989

Volltextzugriff (PDF)

Binding Characteristics of Endothelin Isoforms (ET-1, ET-2, and ET-3) in Vascular Smooth Muscle Cells

Journal of cardiovascular pharmacology, 1991, Vol.17 Suppl 7, p.S104-108

1991

Volltextzugriff (PDF)

Vascular Mechanism of Action of Endothelin-1: Effect of Ca2+ Antagonists

Journal of cardiovascular pharmacology, 1989, Vol.13 Suppl 5, p.S32-35

1989

Volltextzugriff (PDF)

36 Multiplicity of endothelin receptors in cultured rat aortic smooth muscle cells

Journal of hypertension, 1991-09, Vol.9 (9), p.883

1991

Volltextzugriff (PDF)

18 Endothelin receptors and immunoreactivity in human lung

Journal of hypertension, 1991-09, Vol.9 (9), p.875

1991

Volltextzugriff (PDF)

Intracellur signalling pathways and binding of endothelin in vascular smooth muscle cells

European journal of pharmacology, 1990-07, Vol.183 (3), p.676-676

1990

Volltextzugriff (PDF)

Vascular mechanism of action of endothelin-1: Effect of Ca super(2+) antagonists

Journal of cardiovascular pharmacology, 1989-01, Vol.13, p.no. Sul. 5-no. Sul. 5

1989

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(26)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Animals
(10)
Life Sciences & Biomedicine
(10)
Male
(9)
Rats
(8)
Biological And Medical Sciences
(6)
Humans
(6)
Cells, Cultured
(5)
Receptors, Endothelin
(5)
Endothelins - Metabolism
(4)
Kinetics
(4)
Muscle, Smooth, Vascular - Metabolism
(4)
Rats, Inbred Strains
(4)
Receptors, Cell Surface - Metabolism
(4)
Adolescent
(3)
Female
(3)
Ferritins - Blood
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Hematology
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2.420 An improved model of L-DOPA-induced dyskinesia in 6-OHDA lesioned rats

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure

In Vitro Antioxidant Neuroprotective Activity of BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation

Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors

Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6C high Monocyte Subset for Therapeutic Intervention in Arthritis

A9.17Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

A9.17 Targeting the Expression of miR-146a in Mouse Inflammatory Ly6Chigh Monocyte Subset for Therapeutic Intervention in Arthritis

A4.4MIR-146A deficiency in LY6Chigh monocytes contributes to pathogenic bone loss during inflammatory arthritis

A4.4 MIR-146A deficiency in LY6C high monocytes contributes to pathogenic bone loss during inflammatory arthritis

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

Increased rewarding properties of morphine in dopamine-transporter knockout mice

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with -thalassemia major

Continued improvement in myocardial T2 over two years of deferasirox therapy in -thalassemia major patients with cardiac iron overload

410 Antitumoral activity of tasquinimod is mediated through tumour immunomodulatory and antiangiogenic properties in bladder cancer

Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells

Binding Characteristics of Endothelin Isoforms (ET-1, ET-2, and ET-3) in Vascular Smooth Muscle Cells

Vascular Mechanism of Action of Endothelin-1: Effect of Ca2+ Antagonists

36 Multiplicity of endothelin receptors in cultured rat aortic smooth muscle cells

18 Endothelin receptors and immunoreactivity in human lung

Intracellur signalling pathways and binding of endothelin in vascular smooth muscle cells

Vascular mechanism of action of endothelin-1: Effect of Ca super(2+) antagonists

Aktive Filter

Suchergebnisse filtern